CORT vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 24, 2026

CORT

54.7
AI Score
VS
PCRX Wins

PCRX

58.0
AI Score

Investment Advisor Scores

CORT

55score
Recommendation
HOLD

PCRX

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CORT PCRX Winner
Forward P/E 98.0392 7.6104 PCRX
PEG Ratio 0.813 11.2121 CORT
Revenue Growth 4.9% 5.0% PCRX
Earnings Growth -21.6% -30.0% CORT
Tradestie Score 54.7/100 58.0/100 PCRX
Profit Margin 6.2% 0.7% CORT
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.